Scientific Presentations + Publications

Scientific Presentations + Publications

Long-term(180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial

DECEMBER 16, 2022  |
JAMA

Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19

JANUARY 18, 2022  |
JAMA

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

AUGUST 4, 2021  |
NEJM

Adaptive Platform Trials: The Clinical Trial of the Future? (C)

JULY 2021  |
Ariel D. Stern and Sarah Mehta, Harvard Business Review

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

FEBRUARY 25, 2021  |
NEJM

Implementation of the Randomized Embedded Multifactorial Adaptive Platform for COVID-19 (REMAP-COVID) trial in a US health system—lessons learned and recommendations

JANUARY 28, 2021  |
BIOMED CENTRAL

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19. The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial

SEPTEMBER 2, 2020  |
JAMA

Adaptive Platform Trials: The Clinical Trial of the Future? (B)

SEPTEMBER 2019  |
Ariel D. Stern and Sarah Mehta, Harvard Business Review

Adaptive Platform Trials: Definition, Design, Conduct and Reporting Considerations

AUGUST 28, 2019  |
NATURE REVIEWS DRUG DISCOVERY

Adaptive Platform Trials: The Clinical Trial of the Future?

September 26, 2017  |
Ariel D. Stern and Sarah Mehta, Harvard Business Review

 

Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE

September 20, 2017  |
Dr. Brian M. Alexander, Dr. Sujuan Ba, Dr. Webster Cavenee, Dr. Timothy F. Cloughesy, Dr. W.K. Alfred Yung – American Association for Cancer Research

CURRENT COLLABORATIONS + INITIATIVES